VX-770, Cact-A1, and Increased Intracellular cAMP Have Distinct Acute Impacts upon CFTR Activity
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020471 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Heidi J Nick und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Cyclic AMP, Quinolones, Aminophenols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Easton M. Crawford Charitable Lead Unitrust, Cystic Fibrosis Foundation, NHLBI NIH HHS.
Abstract (Originalsprache)
The cystic fibrosis transmembrane conductance regulator (CFTR) is an anion channel that is dysfunctional in individuals with cystic fibrosis (CF). The permeability of CFTR can be experimentally manipulated though different mechanisms, including activation via inducing the phosphorylation of residues in the regulatory domain as well as altering the gating/open probability of the channel. Phosphorylation/activation of the channel is achieved by exposure to compounds that increase intracellular cAMP, with forskolin and IBMX commonly used for this purpose. Cact-A1 is a unique CFTR activator that does not increase intracellular cAMP, and VX-770 (ivacaftor) is a CFTR potentiator that is used experimentally and therapeutically to increase the open probability of the channel. Using primary human nasal epithelial cell (HNEC) cultures and Fischer rat thyroid (FRT) epithelial cells exogenously expressing functional CFTR, we examined the impact of VX-770, Cact-A1, and forskolin/IBMX on CFTR activity during analysis in an Ussing chamber. Relative contributions of these compounds to maximal CFTR activity were dependent on order of exposure, the presence of chemical and electrical gradients, the level of constitutive CFTR function, and the cell model tested. Increasing intracellular cAMP appeared to change cellular functions outside of CFTR activity that resulted in alterations in the drive for chloride through CFTR. These results demonstrate that one can utilize combinations of small-molecule CFTR activators and potentiators to provide detailed characterization of CFTR-mediated ion transport in primary HNECs and properties of these modulators in both primary HNECs and FRT cells. Future studies using these approaches may assist in the identification of novel defects in CFTR function and the identification of modulators with unique impacts on CFTR-mediated ion transport.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA.
- Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
ORCID-Profile: Heidi J Nick, Preston E Bratcher
Förderung
- Easton M. Crawford Charitable Lead Unitrust
- Cystic Fibrosis Foundation
- NHLBI NIH HHS
- NIH HHS
- Department of Pediatrics at National Jewish Health
- National Institutes of Health
Zitieren
APA
Nick, H. J., Christeson, S. E., & Bratcher, P. E. (2025). VX-770, Cact-A1, and Increased Intracellular cAMP Have Distinct Acute Impacts upon CFTR Activity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020471
Vancouver
Nick HJ, Christeson SE, Bratcher PE. VX-770, Cact-A1, and Increased Intracellular cAMP Have Distinct Acute Impacts upon CFTR Activity. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020471
BibTeX
@article{Nick2025,
author = {Nick, Heidi J and Christeson, Sarah E and Bratcher, Preston E},
title = {VX-770, Cact-A1, and Increased Intracellular cAMP Have Distinct Acute Impacts upon CFTR Activity},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020471}
}
EUVIMED